Trials / Withdrawn
WithdrawnNCT05125978
Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
National, Multicenter, Randomized, Double-blind, Triple-dummy, Phase II Clinical Trial to Evaluate the Efficacy and Safety of Canadá Association in the Treatment of Chronic Pain
- Status
- Withdrawn
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- EMS · Industry
- Sex
- All
- Age
- 15 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to evaluate the efficacy and safety of Canadá association in the treatment of chronic pain
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Canadá | Canadá association 1 tablet twice a day |
| OTHER | Canadá placebo | Placebo of Canadá association 1 tablet twice a day |
| DRUG | Dipyrone | Dipyrone 1 tablet twice a day |
| OTHER | Dipyrone placebo | Placebo of dipyrone 1 tablet twice a day |
| DRUG | Tramadol hydrochloride | Tramadol 1 coated tablet twice a day |
| OTHER | Tramadol hydrochloride placebo | Placebo of tramadol 1 coated tablet twice a day |
Timeline
- Start date
- 2026-09-01
- Primary completion
- 2028-07-01
- Completion
- 2028-07-01
- First posted
- 2021-11-18
- Last updated
- 2023-09-08
Source: ClinicalTrials.gov record NCT05125978. Inclusion in this directory is not an endorsement.